Motor assessment in patients with Duchenne muscular dystrophy

Diniz GP, Lasmar LM, Giannetti JG.
Arq Neuropsiquiatr. 2012. 70(6): 416-21.
This study of 20 DMD patients shows the sensitivity of the MFM with six months between two applications.

PubMed link

Keywords: Duchenne muscular dystrophy, MFM, Medical research concil

 

 

Articles dans les revues scientifiques

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial)

Stam M, Wadman RI, Wijngaarde CA, Bartels B, Asselman FL, Otto LAM, Goedee HS, Habets LE, de Groot JF, Schoenmakers MAGC, Cuppen I, van den Berg LH, van der Pol WL. BMJ Open. 2018. 30;8(7):e019932.  Protocol of the "SPACE" in wich MFM is used as an outcome measure....

read more